KK

Khushboo Kumari

Director Director DIN 08703465
DIN 08703465 First appointment Feb 2020 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Feb 2020
Shareholding value β€’β€’β€’β€’ Premium profile

About Khushboo Kumari

Data last updated:

Khushboo Kumari was a Director at Nimbeck India Pharmaceutical Private Limited (2020–2022) and Director at Nhat Pharmaceuticals Private Limited (from 2020). The companies operate in Pharma.

DIN 08703465
Primary Designation Director
Industry Pharma
First Appointment 18 Feb 2020
Oldest Company Age 6 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director14 Jul 20202020Active
Nhat Pharmaceuticals Private Limited U24230BR2020PTC045528
Director18 Feb 20202020Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Nhat Pharmaceuticals Private Limited
Nimbeck India Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Khushboo Kumari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Khushboo Kumari

Khushboo Kumari was first appointed on 18 Feb 2020 as Director at Nhat Pharmaceuticals Private Limited.

Khushboo Kumari held 2 earlier board appointments: Nimbeck India Pharmaceutical Private Limited (Director, 14 Jul 2020 to 30 Nov 2022); Nhat Pharmaceuticals Private Limited (Director, from 18 Feb 2020).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available